"MedEye has grown from being a tool to check and verify all solid oral medications, into becoming a complete medication verification system that handles all medications and various different workflows for e.g. double verification of high risk medications.
It may be more useful for a single solid dosage medication being delivered and monitored as part of a clinical trial than multiple drug use in routine primary care.
Pillbox, run by the National Library of Medicine, helps folks identify unknown solid dose medications (tablets and capsules) based on physical characteristics and images, as well as imprint, shape, color, size, and other information.
These findings and this approach could pave the way for a better design of solid oral medications to address the special needs of children or patients with swallowing disorders and could help designing more successful sensory evaluations and clinical studies.
However despite extensive examination, solid evidence that medication interventions provide lasting long-term benefits remains elusive.
Exclusive breast-feeding (EBF) is the practice of feeding only breast milk (including expressed breast milk) during the first six months and no other liquids and solid foods except medications.
We included all immunocompromised patients defined as patients with any of the following: HIV infection (all stages), neutropenia (neutrophil count < 1 × 10/L), exposure to glucocorticoids (> 0.5 mg/kg for > 30 d) and/or immunosuppressive or cytotoxic medications, solid organ transplantation, allogeneic or autologous stem cell transplantation, hematological malignancy, or solid tumor.
According to World Health Organization and Ethiopian national strategy for infant and young child feeding, exclusive breast-feeding (EBF) is the practice of feeding only breast milk (including expressed breast milk) during the first six months and no other liquids and solid foods except medications [ 1, 2].
Medication competence requires a solid knowledge base in pharmacology, pharmacy and medication management (theoretical medication competence).
Refers to patients with immune suppression not related to cancer (for example, those receiving immune suppressive medication for solid organ transplantation, or those with a primary immune deficiency).
